← Evidence map

ArticleFrontiers in immunology2025

Engineered NK92 cell-derived exosomes inhibit ovarian cancer progression by degrading

Chaohua Si et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41306963